SMITHKLINE ORAL KYTRIL ON SLOAN-KETTERING FORMULARY; HOSPITALS FIND KYTRIL MORE COST-EFFECTIVE THAN GLAXO WELLCOME'S ZOFRAN IN MANY CASES: SALES DOWN
Executive Summary
The Memorial Sloan-Kettering Cancer Center now uses SmithKline Beecham's oral formulation of Kytril (granisetron) almost exclusively in treating patients with moderate or severe chemotherapy-induced nausea and vomiting.